Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

2 235 evidences · page 76 / 90

17,3 ng/mlCirculating 25(OH)D levels were significantly lower in HAART-experienced participants (median, 17.3 ng/ml; IQR, 18.3 ng/ml) compared to uninfected PWID (median, 25.6 ng/ml; IQR, 6.8 ng/ml).

KenyaVIH/sidapublié 2024BMC infectious diseasesPubMeddocument de 10 observations

19 countiesNineteen counties in Kenya were classified as having mixed HIV epidemics.

KenyaVIH/sidapublié 2024Journal of the International AIDS SocietyPubMeddocument de 5 observations

2,11 odds_ratioThe odds of HIV were higher among married women with younger versus older male sexual partners (adjusted odds ratio: 2.11).

KenyaVIH/sidaobservé 2011-2022publié 2025BMC public healthPubMeddocument de 12 observations

11,8 %Among 502 pregnant women in Kenya enrolled during pregnancy and followed for 6 months postpartum, 11.8% were HIV-positive.

KenyaVIH/sidapublié 2022International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 6 observations

The broad NRTI cross-resistance mutation K65R was observed.

KenyaVIH/sidapublié 2009AIDS research and therapyeurope_pmcdocument de 8 observations

86 individualsAmong 175 participants, 86 (49.1%) were HIV-positive.

KenyaVIH/sidapublié 2020International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 4 observations

93,9 %At 3 months, 93.9% of the intervention arm and 73.9% of the comparison arm reported that partner testing occurred.

KenyaVIH/sidaobservé 3 monthspublié 2023The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument de 7 observations

59,8 %Modeled HIV prevalence among inherited widowed women was 59.8% (95% CI: 59.5–60.2%).

KenyaVIH/sidapublié 2025BMC medicinePubMeddocument de 2 observations

1 caseOne participant in the standard of care group was withdrawn at the 6-month visit due to HIV seroconversion.

KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 10 observations

45 %Intravaginal insertion of lemon juice was reported by 45% of 58 HIV-1-uninfected Kenyan women reporting intravaginal practices.

KenyaVIH/sidapublié 2014AIDS research and human retroviruseseurope_pmcdocument de 6 observations

57 %57% of the participants preferred that their caregivers disclose their HIV status to them.

KenyaVIH/sidaobservé 2019publié 2023Frontiers in public healthPubMeddocument de 18 observations

74,9 %Among 275 participants in an HIV incidence cohort in Kenya who had heard of PrEP, 206 (74.9%) had never taken it.

KenyaVIH/sidapublié 2024Journal of the International AIDS SocietyPubMeddocument de 6 observations

2 participantsTwo participants had virological failure in the long-acting therapy group, both with drug resistance.

KenyaVIH/sidapublié 2024The Lancet. Infectious diseasesPubMeddocument de 10 observations

14,5 %HIV prevalence was 14.5% among the study population in western Kenya.

KenyaVIH/sidapublié 2026Global health actionPubMeddocument de 7 observations

3 foldRisk of HIV transmission was three to fourfold higher at visits with fertility intent compared to visits with fertility desire when condomless sex and PSA detection occurred concurrently.

KenyaVIH/sidapublié 2023AIDS and behavioreurope_pmcdocument de 3 observationsDOI 10.1007/s10461-023-04004-4

60 %Three of five mother-infant pairs (60%) harbored HIV drug resistance mutations.

KenyaVIH/sidapublié 2022The Pediatric infectious disease journalPubMed

12 %Among 423 HIV-negative Kenyan men who have sex with men and transgender women, condoms were preferred by 12% in pairwise comparisons.

KenyaVIH/sidapublié 2023AIDS and behaviorPubMeddocument de 9 observations

14 %In 2020, 14% of diagnosed persons living with HIV in Kenya were not taking antiretroviral therapy.

KenyaVIH/sidaobservé 2020publié 2024BMC infectious diseasesPubMeddocument de 2 observations

19,7 %Among 2386 partners of HIV-positive persons who inject drugs in Kenya, 469 (19.7%) tested HIV positive.

KenyaVIH/sidapublié 2022BMC infectious diseasesPubMeddocument de 4 observations

11 %Fingerprint technology had a false rejection rate of 11% for unique patient matching and identification in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublié 2021Journal of medical Internet researchPubMeddocument de 11 observations

94,2 %Among 208 HIV-infected ART-naïve adults in Kenya, 196 (94.2%) were hepatitis B surface antigen (HBsAg) negative.

Kenyahépatite B · VIH/sidapublié 2021PloS onePubMeddocument de 7 observations

60 %Among 194 adolescents living with HIV (ALH), 60% had undetectable HIV viral load (<20 copies/ml).

KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 14 observations

0,36 p_valueThere was no change in HIV plasma viral load (P = 0.36).

KenyaVIH/sidapublié 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 3 observations

97,8 %Among 940 individuals screened for enrollment into the HIV incidence study, 919 (97.8%) reported willingness to participate in a future clinical trial of a candidate HIV vaccine.

KenyaVIH/sidaobservé From February 2017 to May 2018publié 2026BMC public healthPubMeddocument de 10 observations

77 %Out of the 216 sexual partners, 77% were reached and tested.

KenyaVIH/sidaobservé January 2017 to August 2018publié 2020BMC infectious diseasesPubMeddocument de 6 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.